
Journal of Medicinal Chemistry p. 953 - 966 (1993)
Update date:2022-08-04
Topics:
Hoffman
Smith
Rooney
Fisher
Wai
Thomas
Bamberger
Barnes
Williams
Jones
Olson
O'Brien
Goldman
Nunberg
Quintero
Schleif
Emini
Anderson
A new series of potent specific 2-pyridinone reverse transcriptase (RT) inhibitors was developed based on the preliminary development lead 3- [(phthalimido)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (3), a non-nucleoside derivative which exhibited weak anti
View MoreContact:+86-13914766747
Address:Floors 21&22, Jin Cheng Tower, No. 216 Middle Longpan Road, Nanjing
Contact:0572-2722882
Address:1201,F3,xinghuibandao,
Contact:86-571-87758773
Address:Room604 ,6F, Block A1-3 Xixi Plaza,No. 588 Wenyi West RD, Hangzhou,310012, China
Shanghai KFSL Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-39971718
Address:859 jiadingchengliu shanghai
Contact:
Address:ROOM 1715, No#345 Jin Xiang Road, Pudong District
Doi:10.1007/BF00664830
()Doi:10.1002/pola.26803
(2013)Doi:10.1039/b109781d
(2002)Doi:10.1002/ejoc.200800771
(2008)Doi:10.1021/jacs.8b07776
(2018)Doi:10.1016/0040-4039(93)89003-9
(1993)